ICU Medical's first quarter 2022 revenue was $543.1 million, a significant increase from $318.0 million in the same period last year, primarily due to the acquisition of Smiths Medical. However, the company reported a GAAP net loss of $(38.1) million, or $(1.61) per diluted share, compared to a net income of $23.7 million, or $1.09 per diluted share, for the first quarter of 2021.
First quarter revenue reached $543.1 million, up from $318.0 million year-over-year.
GAAP gross profit was $168.8 million, compared to $112.7 million in the same period last year.
GAAP net loss was $(38.1) million, or $(1.61) per diluted share, a decrease from net income of $23.7 million, or $1.09 per diluted share, in the first quarter of 2021.
Adjusted diluted earnings per share was $1.82, compared to $1.62 for the first quarter of 2021.
This press release contains forward-looking statements, and actual results and events could differ materially from those projected due to various risks and uncertainties.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance